Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	110.35	71.48	487.73	343.26	219.7	287
Short-Term Investments	-	-	-	-	30.08	-
Trading Asset Securities	468.26	459.67	102.98	59.84	70.16	-
Cash & Short-Term Investments	578.6	531.15	590.72	403.11	319.94	287
Cash Growth	-6.36%	-10.08%	46.54%	25.99%	11.48%	355.44%
Accounts Receivable	205.44	199.03	198.53	264	254.84	276.45
Other Receivables	19.13	15.36	11.75	22.23	39.61	34.13
Receivables	224.58	214.39	210.28	286.23	294.45	310.59
Inventory	1,616	1,626	1,617	1,603	1,597	1,616
Other Current Assets	7.85	3.75	13.32	10.17	10.53	10.01
Total Current Assets	2,427	2,376	2,431	2,303	2,222	2,223
Property, Plant & Equipment	441.29	450.34	483.66	526.11	501.49	423.3
Long-Term Investments	-	15.23	-	-	-	-
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Intangible Assets	110.69	111.35	114.18	117.03	119.96	123.41
Long-Term Deferred Tax Assets	13.16	13.15	12.62	14.2	15.2	17.87
Long-Term Deferred Charges	1.86	2.15	2.02	3.07	2.99	4.1
Other Long-Term Assets	16.95	0.76	1.27	1.68	1.04	2.16
Total Assets	3,012	2,971	3,047	2,967	2,864	2,796
Accounts Payable	13.6	13	24.86	24.33	19.81	24.8
Accrued Expenses	7.99	22.26	32.51	30.68	48.11	20.58
Short-Term Debt	345.02	290.28	470.43	430.43	397.86	405.4
Current Portion of Long-Term Debt	3.82	-	-	-	2.55	10
Current Portion of Leases	-	2.98	2.34	3.29	3.31	-
Current Income Taxes Payable	9.61	0.01	2.78	0.64	5.55	3.09
Current Unearned Revenue	5.38	5.49	11.01	24.51	16.72	41.47
Other Current Liabilities	29.25	31.55	45.91	74.29	39.84	69.18
Total Current Liabilities	414.67	366	589.85	588.16	533.75	574.52
Long-Term Debt	134.7	149.7	-	-	-	2.55
Long-Term Leases	3.62	6.21	4.03	9.82	11.46	-
Long-Term Unearned Revenue	111.38	112.54	118.69	118.02	120.85	86.79
Long-Term Deferred Tax Liabilities	2.58	2.77	1.74	1.17	0.02	-
Total Liabilities	666.96	637.22	714.3	717.18	666.08	663.86
Common Stock	330.95	330.95	330.95	330.95	330.95	330.95
Additional Paid-In Capital	834.69	834.69	834.69	834.69	834.69	834.69
Retained Earnings	1,082	1,070	1,068	989.34	916.17	830.08
Total Common Equity	2,247	2,236	2,233	2,155	2,082	1,996
Minority Interest	98	97.83	99.26	94.45	116.47	136.52
Shareholders' Equity	2,345	2,333	2,332	2,249	2,198	2,132
Total Liabilities & Equity	3,012	2,971	3,047	2,967	2,864	2,796
Total Debt	487.15	449.59	476.8	443.55	415.18	417.95
Net Cash (Debt)	91.45	81.56	113.92	-40.44	-95.24	-130.96
Net Cash Growth	-35.79%	-28.40%	-	-	-	-
Net Cash Per Share	0.28	0.25	0.34	-0.12	-0.29	-0.40
Filing Date Shares Outstanding	331.33	330.95	330.95	330.95	330.95	330.95
Total Common Shares Outstanding	331.33	330.95	330.95	330.95	330.95	330.95
Working Capital	2,012	2,010	1,841	1,714	1,688	1,649
Book Value Per Share	6.78	6.76	6.75	6.51	6.29	6.03
Tangible Book Value	2,135	2,122	2,117	2,036	1,960	1,870
Tangible Book Value Per Share	6.44	6.41	6.40	6.15	5.92	5.65
Buildings	-	548.14	548.14	545.7	400.71	400.4
Machinery	-	353.49	359	357.13	321.57	317.93
Construction In Progress	-	-	-	1.98	119.32	27.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.